Bank of Montreal
LYRA

Bank of Montreal’s LYRA THERAPEUTICS INC LYRA Stock Holding History

Bank of Montreal’s Portfolio LYRA Stock Details LYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,083
Closed -$11.2K – 3639
2024
Q4 		$11.2K Sell
1,083
-1,305
-55% -$14.4K ﹤0.01% 3326
2024
Q3 		$31.7K Buy
+2,388
New +$35.1K ﹤0.01% 3503
2024
Q2 		– Sell
-278
Closed -$82.3K – 4096
2024
Q1 		$82.3K Buy
+278
New +$74.1K ﹤0.01% 3328
2021
Q2 		– Sell
-4
Closed -$2K – 4400
2021
Q1 		$2K Sell
4
-19
-83% -$11.9K ﹤0.01% 4909
2020
Q4 		$12K Buy
23
+19
+475% +$10.7K ﹤0.01% 4614
2020
Q3 		$2K Sell
4
-3
-43% -$1.86K ﹤0.01% 4634
2020
Q2 		$4K Buy
+7
New +$5.12K ﹤0.01% 4453

Other funds holding LYRA

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of Montreal's LYRA Position: Q1 2025 in Review

Bank of Montreal sold out of LYRA THERAPEUTICS INC (LYRA) in Q1 2025, closing a stake of 1,083 shares — an estimated $11.2K sold.

Bank of Montreal first reported a position in LYRA in Q2 2020 and held it in 7 quarters. The position peaked at $82.3K in Q1 2024. 57 funds tracked by Wall St. Rank hold LYRA as of Q1 2025.

  • Bank of Montreal reported no remaining LYRA THERAPEUTICS INC position as of Q1 2025 after selling out during the quarter.
  • Bank of Montreal sold 1,083 LYRA THERAPEUTICS INC shares in Q1 2025, an estimated $11.2K.
  • Bank of Montreal first reported a position in LYRA THERAPEUTICS INC in Q2 2020 and held it in 7 quarters.
  • Bank of Montreal's LYRA THERAPEUTICS INC position peaked at $82.3K in Q1 2024.
  • 57 funds tracked by Wall St. Rank held LYRA THERAPEUTICS INC as of Q1 2025.

Based on Bank of Montreal's 13F filing for Q1 2025, filed 13 May 2025.